Xiao-Qing Gu
Overview
Explore the profile of Xiao-Qing Gu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong B, Gu X, Chen H, Gu J, Pan Z
J Am Med Dir Assoc
. 2021 Jun;
22(12):2571-2578.e4.
PMID: 34129830
Objective: Frailty state progression is common among older adults, so it is necessary to identify predictors to implement individualized interventions. We aimed to develop and validate a nomogram to predict...
2.
Li J, Shen W, Gu X, Hong W, Wang Z
Jpn J Clin Oncol
. 2017 Mar;
47(6):487-493.
PMID: 28334806
Objective: This study aims to explore the prognostic value of endoscopic ultrasonography combined with multi-slice spiral computed tomography in predicting the recurrence and metastasis of gastric cancer, as well as...
3.
Copeland S, Ladd L, Gu X, Mather L
Anesth Analg
. 2008 Apr;
106(5):1440-9, table of contents.
PMID: 18420858
Background: Local anesthetic toxicity is often studied experimentally in anesthetized subjects, but clinical toxicity usually occurs in conscious patients. In this study, we determined the influence of general anesthesia on...
4.
Copeland S, Ladd L, Gu X, Mather L
Anesth Analg
. 2008 Apr;
106(5):1429-39, table of contents.
PMID: 18420857
Background: Local anesthetic toxicity is often studied experimentally in acutely prepared, anesthetized laboratory animals. We determined the influence of halothane/O(2) anesthesia on cardiovascular and central nervous system (CNS) toxic responses...
5.
Murphy S, Davey R, Gu X, Haywood M, McCann L, Mather L, et al.
J Neurooncol
. 2007 May;
85(2):181-9.
PMID: 17534579
With the aim of improving the treatment of glioblastoma multiforme, we investigated the potential of thalidomide to enhance the effectiveness of cisplatin chemotherapy in a rat glioma model. Female F344...
6.
Murphy S, Boyle F, Davey R, Gu X, Mather L
J Pharm Pharmacol
. 2007 Jan;
59(1):105-14.
PMID: 17227627
Thalidomide is currently under evaluation as an anti-angiogenic agent in cancer treatment, alone and in combination with cytotoxic agents. Thalidomide is a racemate with known pharmacologic and pharmacokinetic enantioselectivity. In...